Pages that link to "Q37685088"
Jump to navigation
Jump to search
The following pages link to Pharmacological considerations in the design of anti-malarial drug combination therapies - is matching half-lives enough? (Q37685088):
Displaying 11 items.
- Mathematical Modelling to Guide Drug Development for Malaria Elimination (Q28067367) (← links)
- Altering Antimalarial Drug Regimens May Dramatically Enhance and Restore Drug Effectiveness. (Q36075783) (← links)
- How Robust Are Malaria Parasite Clearance Rates as Indicators of Drug Effectiveness and Resistance? (Q36076111) (← links)
- Quantifying the pharmacology of antimalarial drug combination therapy. (Q37283299) (← links)
- Use of quantitative pharmacology tools to improve malaria treatments (Q38664529) (← links)
- Antimalarial drug resistance: linking Plasmodium falciparum parasite biology to the clinic (Q40106428) (← links)
- Pharmacokinetic studies of antimalarials: recent developments (Q43848645) (← links)
- Optimal control of malaria: combining vector interventions and drug therapies. (Q52881142) (← links)
- Multidrug-resistant malaria and the impact of mass drug administration. (Q53702249) (← links)
- Quantum Chemical Lipophilicities of Antimalarial Drugs in Relation to Terminal Half-Life (Q91657582) (← links)
- The genomic architecture of antimalarial drug resistance (Q92231044) (← links)